Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Published

Journal Article

The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care.

Full Text

Duke Authors

Cited Authors

  • Benson, AB; Venook, AP; Al-Hawary, MM; Cederquist, L; Chen, Y-J; Ciombor, KK; Cohen, S; Cooper, HS; Deming, D; Engstrom, PF; Grem, JL; Grothey, A; Hochster, HS; Hoffe, S; Hunt, S; Kamel, A; Kirilcuk, N; Krishnamurthi, S; Messersmith, WA; Meyerhardt, J; Mulcahy, MF; Murphy, JD; Nurkin, S; Saltz, L; Sharma, S; Shibata, D; Skibber, JM; Sofocleous, CT; Stoffel, EM; Stotsky-Himelfarb, E; Willett, CG; Wuthrick, E; Gregory, KM; Freedman-Cass, DA

Published Date

  • July 2018

Published In

Volume / Issue

  • 16 / 7

Start / End Page

  • 852 - 871

PubMed ID

  • 30006428

Pubmed Central ID

  • 30006428

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2018.0060

Language

  • eng

Conference Location

  • United States